Display options
Cite
Riveline JP, Vergés B, Detournay B, et al. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab. 2021;48(3):101306doi: 10.1016/j.diabet.2021.101306.
Riveline, J. P., Vergés, B., Detournay, B., Picard, S., Benhamou, P. Y., Bismuth, E., Bordier, L., Jeandidier, N., Joubert, M., Roussel, R., Sola-Gazagnes, A., Bonnefond, A., Clavel, S., Velayoudom, F. L., Beltrand, J., Hanaire, H., Fontaine, P., Thivolet, C., Servy, H., Tubiana, S., Lion, S., Gautier, J. F., Larger, E., Vicaut, E., Sablone, L., Fagherazzi, G., & Cosson, E. (2021). Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes & metabolism, 48(3), 101306. https://doi.org/10.1016/j.diabet.2021.101306
Riveline, J P, et al. "Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study." Diabetes & metabolism vol. 48,3 (2021): 101306. doi: https://doi.org/10.1016/j.diabet.2021.101306
Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab. 2021 Nov 21;48(3):101306. doi: 10.1016/j.diabet.2021.101306. Epub 2021 Nov 21. PMID: 34813929.
Copy Download .nbib Format: NLM
Share it on

Diabetes Metab. 2021 Nov 21;48(3):101306. doi: 10.1016/j.diabet.2021.101306. Epub 2021 Nov 21.

Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study.

Diabetes & metabolism

J P Riveline, B Vergés, B Detournay, S Picard, P Y Benhamou, E Bismuth, L Bordier, N Jeandidier, M Joubert, R Roussel, A Sola-Gazagnes, A Bonnefond, S Clavel, F L Velayoudom, J Beltrand, H Hanaire, P Fontaine, C Thivolet, H Servy, S Tubiana, S Lion, Jean-François Gautier, Etienne Larger, E Vicaut, L Sablone, G Fagherazzi, E Cosson

Affiliations

  1. Department of Diabetology and Endocrinology, Lariboisiere Hospital, Assistance Publique - Hôpitaux de Paris, Lariboisière Hospital, 2 rue Ambroise Paré, Paris 75010, France; Unite INSERM U1138 Immunity and Metabolism in Diabetes, ImMeDiab Team, Centre de Recherches des Cordeliers, and Universite de Paris, Paris, France. Electronic address: [email protected].
  2. Department of Endocrinology-Diabetology, INSERM LNC UMR1231, University of Burgundy, Dijon, France.
  3. CEMKA, 43 boulevard du Maréchal Joffre, Bourg-la-Reine, France.
  4. Endocrinology and Diabetes, Point Medical, Rond-Point de la Nation, Dijon 21000, France.
  5. INSERM U1055, LBFA, Endocrinologie, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
  6. Hôpital Universitaire Robert-Debré, Service d'Endocrinologie Diabétologie Pédiatrique, Université de Paris, Paris F-75019, France.
  7. Department of Diabetology and Endocrinology, Begin Military Hospital, Saint Mandé, France.
  8. Department of Endocrinology, Diabetes, Nutrition, Hospices Civils Strasbourg, UdS, Strasbourg 67000, France.
  9. Diabetes Care Unit - Caen University Hospital - UNICAEN, Caen, France.
  10. Department of Diabetology, Endocrinology, and Nutrition, Bichat-Claude Bernard Hospital, Paris,France; Unite INSERM U1138 Immunity and Metabolism in Diabetes, ImMeDiab Team, Centre de Recherches des Cordeliers, and Universite de Paris, Paris, France.
  11. Department of Diabetology, Cochin Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
  12. Université de Lille, Inserm UMR1283, CNRS UMR8199, Institut Pasteur de Lille, CHU de Lille, Lille, France.
  13. Department of Diabetology Endocrinology Hotel Dieu Le Creusot, France.
  14. Department of Diabetology and Endocrinology, University Hospital of Guadeloupe, Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille University Hospital, Lille 59000, France.
  15. Endocrinologie, Gynécologie et Diabétologie Pédiatrique, APHP Centre, Hôpital Universitaire Necker Enfants Malades, Université de Paris - Inserm U1016, Institut Cochin, Paris, France.
  16. Department of Diabetology, University Hospital of Toulouse, University of Toulouse, France.
  17. Department of Endocrinology, Diabetology and Nutrition University Hospital of Lille, University of Lille, France.
  18. Center for Diabetes DIAB-eCARE, Hospices Civils de Lyon and Lyon 1 University, Lyon France.
  19. e-health Services Sanoïa, 188 av 2nd DB, Gémenos 13420, France.
  20. AP-HP, Hôpital Bichat, Centre de Ressources Biologiques, Paris F-75018, France.
  21. Société Francophone du Diabète, Paris, France.
  22. Department of Diabetology and Endocrinology, Lariboisiere Hospital, Assistance Publique - Hôpitaux de Paris, Lariboisière Hospital, 2 rue Ambroise Paré, Paris 75010, France; Unite INSERM U1138 Immunity and Metabolism in Diabetes, ImMeDiab Team, Centre de Recherches des Cordeliers, and Universite de Paris, Paris, France.
  23. AP-HP.Centre-Université de Paris, INSERM U1016, Institut Cochin Paris, France.
  24. AP-HP, Hôpital F.Widal, Clinical Trial Unit, Paris 75010, France.
  25. Fondation Francophone Pour la Recherche sur le Diabète, 60 rue Saint Lazare, Paris 75009, France.
  26. Department of Population Health, Deep Digital Phenotyping Research Unit, 1 AB rue Thomas Edison, Strassen, Luxembourg.
  27. Department of Endocrinology-Diabetology-Nutrition, CRNH-IdF, CINFO, AP-HP, Avicenne Hospital, Paris 13 University, Bobigny, France; UMR 557 INSERM/U11125 INRAE/CNAM / Université Paris 13, Unité de Recherche Epidémiologique Nutritionnelle, Paris 13 University Sorbonne Paris Cité, Bobigny, France.

PMID: 34813929 DOI: 10.1016/j.diabet.2021.101306

Abstract

Type 1 diabetes mellitus (T1DM) is associated with a high risk of cardiovascular (CV) complications, even after controlling for traditional CV risk factors. Therefore, determinants of the residual increased CV morbidity and mortality remain to be discovered. This prospective cohort of people living with T1DM in France (SFDT1) will include adults and children aged over six years living with T1DM, recruited throughout metropolitan France and overseas French departments and territories. The primary objective is to better understand the parameters associated with CV complications in T1DM. Clinical data and biobank samples will be collected during routine visits every three years. Data from connected tools, including continuous glucose monitoring, will be available during the 10-year active follow-up. Patient-reported outcomes, psychological and socioeconomic information will also be collected either at visits or through web questionnaires accessible via the internet. Additionally, access to the national health data system (Health Data Hub) will provide information on healthcare and a passive 20-year medico-administrative follow-up. Using Health Data Hub, SFDT1 participants will be compared to non-diabetic individuals matched on age, gender, and residency area. The cohort is sponsored by the French-speaking Foundation for Diabetes Research (FFRD) and aims to include 15,000 participants.

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Keywords: Cardiovascular risk factors; Cohort; Glucose variability; Hypoglycaemia; Macroangiopathy; Quality of life; Type 1 diabetes

Publication Types